Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 Apr 2.

Published in final edited form as: J Neuroimmune Pharmacol. 2011 Aug 9;6(4):551–565. doi: 10.1007/s11481-011-9303-6

Mice were implanted with either a morphine pellet or a placebo pellet 48 hours before i.p. infection with a 0.1 LD₅₀ dose (C57BL/6 mice; A. baumannii, strain 5798, 6.5 × 10⁵ CFU; Panel A) or a 0.4 LD₅₀ dose (C3HeB/FeJ mice; A. baumannii, strain 4502, 1.7 × 10⁶ CFU; Panel B) of A. baumannii. Plasma was collected at 8 hours post-infection for analysis by Cytometric Bead Array. Points represent individual animals. Lines are median values for cytokine levels.

Mice were implanted with either a morphine pellet or a placebo pellet 48 hours before i.p. infection with a 0.1 LD₅₀ dose (C57BL/6 mice; A. baumannii, strain 5798, 6.5 × 10⁵ CFU; Panel A) or a 0.4 LD₅₀ dose (C3HeB/FeJ mice; A. baumannii, strain 4502, 1.7 × 10⁶ CFU; Panel B) of A. baumannii. Plasma was collected at 8 hours post-infection for analysis by Cytometric Bead Array. Points represent individual animals. Lines are median values for cytokine levels.